Glutathione transferase omega 1-1 (GSTO1-1) plays an anti-apoptotic role in cell resistance to cisplatin toxicity

Carcinogenesis

Volumn 31, Issue 5, 2010, Pages 804-811

  Piaggi, Simona ^a   Raggi, Chiara ^a   Corti, Alessandro ^a   Pitzalis, Emanuela ^b   Mascherpa, Marco C ^b   Saviozzi, Michela ^a   Pompella, Alfonso ^a   Casini, Alessandro F ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE OMEGA 1-1; MITOGEN ACTIVATED PROTEIN KINASE 1; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; GLUTATHIONE; GSTO1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE 1;

APOPTOSIS; ARTICLE; CELL DENSITY; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG RESISTANCE; GEL ELECTROPHORESIS; GENE ACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; COMET ASSAY; DRUG EFFECT; GENETICS; HELA CELL; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL SURVIVAL; CISPLATIN; COMET ASSAY; DRUG RESISTANCE, NEOPLASM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HELA CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 8; PROTO-ONCOGENE PROTEINS C-AKT; TRANSFECTION;

EID: 77952310056     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq031     Document Type: Article

References (46)

1. Board, P.G. et al. (2000) Identification, characterization, and crystal structure of the Omega class glutathione transferases. J. Biol. Chem., 275, 24798-24806.
2. Maellaro, E. et al. (1994) Purification and characterization of glutathione-dependent dehydroascorbate reductase from rat liver. Biochem. J., 301, 471-476.
3. Ishikawa, T. et al. (1998) Molecular cloning and functional expression of rat liver glutathione-dependent dehydroascorbate reductase. J. Biol. Chem., 273, 28708-28712.
4. Kodym, R. et al. (1999) The cloning and characterization of a new stress response protein. A mammalian member of a family of theta class glutathione S-transferase-like proteins. J. Biol. Chem., 274, 5131-5137.
5. Wilson, R. et al. (1994) 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans. Nature, 368, 32-38.
6. Rouimi, P. et al. (2001) Purification and characterization of a glutathione S-transferase Omega in pig: evidence for two distinct organ-specific transcripts. Biochem. J., 358, 257-262.
7. Girardini, J. et al. (2002) Characterization of an omega-class glutathione S-transferase from Schistosoma mansoni with glutaredoxin-like dehydroascorbate reductase and thiol transferase activities. Eur. J. Biochem., 269, 5512-5521.
8. Whitbread, A.K. et al. (2005) Characterization of the omega class of glutathione transferases. Methods Enzymol., 401, 78-102.
9. Xu, D.P. et al. (1996) Purification and characterization of a glutathione dependent dehydroascorbate reductase from human erythrocytes. Biochem. Biophys. Res. Commun., 221, 117-121.
10. Schmuck, E.M. et al. (2005) Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activity of Omega class glutathione transferase variant. Pharmacogenet. Genomics, 15, 493-501.
11. Whitbread, A.K. et al. (2003) Characterization of human Omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics, 13, 31-144.
12. Laliberte, R.E. et al. (2003) Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing. J. Biol. Chem., 278, 16567-16578.
13. Dulhunty, A. et al. (2001) The glutathione transferase structural family includes a nuclear chloride channel and a ryanodine receptor calcium release channel modulator. J. Biol. Chem., 276, 3319-3323.
14. Marahatta, S.B. et al. (2006) Polymorphism of glutathione S-transferase Omega gene and risck of cancer. Cancer Lett., 236, 276-281.
15. Pangstaporn, W. et al. (2006) Genetic alteration in chromosome 10q24.3 and glutathione S-transferase Omega 2 polymorphism in ovarian cancer. J. Exp. Clin. Cancer Res., 25, 107-114.
16. Chen, J.H. et al. (2009) Comparative proteomic analysis of differentially expressed proteins in human pancreatic cancer tissue. Hepatobiliary Pancreat. Dis. Int., 8, 193-220.
17. Yan, X.D. et al. (2007) Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines. J. Proteome Res., 6, 772-780.
18. Kartalou, M. et al. (2001) Mechanisms of resistance to cisplatin. Mutat. Res., 478, 23-24.
19. Rabik, C.A. et al. (2007) Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev., 33, 9-23.
20. Schmid, I. et al. (2007) Live-cell assay for detection of apoptosis by duallaser flow cytometry using Hoechst 33342 and 7-amino-actinomycin D. Nat. Protoc., 2, 187-190.
21. Olive, P.L. et al. (1995) Sizing highly fragmented DNA in individual apoptotic cells using the comet assay and a DNA crosslinking agent. Exp. Cell Res., 221, 19-26.
22. Hartley, J.M. et al. (1999) Measurement of DNA cross-linking in patients on ifosfamide therapy using the single cell gel electrophoresis (comet) assay. Clin. Cancer Res., 5, 507-512.
23. Merk, O. et al. (1999) Detection of crosslinks with the comet assay in relationship to genotoxicity and cytotoxicity. Environ. Mol. Mutagen., 33, 167-172.
24. Almeida, G.M. et al. (2006) Detection of oxaliplatin-induced DNA crosslinks in vitro and in cancer patients using the alkaline comet assay. DNA Repair, 5, 219-225.
25. Spanswick, V.J. et al. (2002) Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. Blood, 100, 224-229.
26. Baker, M.A. et al. (1990) Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal. Biochem., 190, 360-365.
27. Priesner, D. et al. (1981) Energy-dispersive X-ray fluorescence determination of platinum in plasma, urine, and cerebrospinal fluid of patients administered cis-dichlorodiammineplatinum(II). Anal. Lett., 14, 1255- 1268.
28. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
29. Towbin, H. et al. (1976) Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl Acad. Sci. USA, 76, 4350-4354.
30. Mehlen, P. et al. (1996) Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha-induced cell death. EMBO J., 15, 2695-2706.
31. Rudin, C.M. et al. (2003) Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance. Cancer Res., 15, 312-318.
32. Burmeister, C. et al. (2008) Oxidative stress in Caenorhabditis elegans: protective effects of the Omega class glutathione transferase (GSTO-1). FASEB J., 22, 343-354.
33. Beale, E.G. et al. (1991) Culture at high density increases phosphoenolpyruvate carboxykinase messenger RNA in H4IIEC3 hepatoma cells. Mol. Endocrinol., 5, 661-669.
34. Garrido, C. et al. (1997) HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res., 57, 2661-2667.
35. Oesterreich, S. et al. (1993) The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res., 53, 4443-4448.
36. Richards, E.H. et al. (1996) Effect of overexpression of the small heat shock protein HSP27 on the heat and drug sensitivities of human testis tumor cells. Cancer Res., 56, 2446-2451.
37. Schmuck, E. et al. (2008) Deletion of Glu155 causes a deficiency of glutathione transferase Omega 1-1 but does not alter sensitivity to arsenic trioxide and other cytotoxic drugs. Int. J. Biochem. Cell Biol., 40, 2553-2559.
38. Cho, S.G. et al. (2001) Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J. Biol. Chem., 276, 12749-12755.
39. Dorion, S. et al. (2002) Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1. J. Biol. Chem., 277, 30792-30797.
40. Townsend, D. et al. (2003) The role of glutathione-S-transferase in anticancer drug resistance. Oncogene, 22, 7369-7375.
41. Adler, V. et al. (1999) Regulation of JNK signaling by GSTp. EMBO J., 18, 1321-1334.
42. Yin, Z. et al. (2000) Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases. Cancer Res., 60, 4053-4057.
43. Datta, S.R. et al. (1999) Cellular survival: a play in three Akts. Genes Dev., 13, 2905-2927.
44. Yuan, Z.Q. et al. (2003) AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. J. Biol. Chem., 278, 23432-23440.
45. Dhanasekaran, D.N. et al. (2008) JNK signaling in apoptosis. Oncogene, 27, 6245-6251.
46. 1 cell cycle progression and cancer. Cancer Sci., 97, 697-702.